Tuberculosis Vaccines

BCG, or bacille Calmette-Guerin (Tuberculosis Vaccines), is a vaccine for tuberculosis (TB) disease. Many foreign-born persons have been BCG-vaccinated. BCG is used in many countries with a high prevalence of TB to prevent childhood tuberculous meningitis and miliary disease. However, Tuberculosis Vaccine is not generally recommended for use in the United States because of the low risk of infection with Mycobacterium tuberculosis, the variable effectiveness of the vaccine against adult pulmonary TB, and the vaccine’s potential interference with tuberculin skin test reactivity. The Tuberculosis Vaccine should be considered only for very select persons who meet specific criteria and in consultation with a TB expert.

  • TB vaccine development
  • Scientific challenges facing the TB vaccine field
  • Next Generation TB Vaccines and Vaccine Concepts

Related Conference of Tuberculosis Vaccines

July 27-28, 2017

International Vaccines Congress

Chicago, USA
August 21-22, 2017

17th International Conference on Children Vaccines

Birmingham, UK
September 18-19, 2017

20th Global Summit & Expo on Vaccines & Immunization

(10 Plenary Forums-1Event) Houston, USA
July 27-28, 2017

19th International Vaccines Congress

Chicago, USA
October 05-07, 2017

World Vaccines and Immunization Congress

Osaka, Japan
November 30-December 01, 2017

23rd Global Vaccines & Vaccination Summit

Dubai, UAE

Tuberculosis Vaccines Conference Speakers

Recommended Sessions

Related Journals

Are you interested in